Suppr超能文献

全基因组小 RNA 测序鉴定出功能获得性突变 p53 非小细胞肺癌中失调的 microRNAs。

Genome-Wide Small RNA Sequencing Identifies MicroRNAs Deregulated in Non-Small Cell Lung Carcinoma Harboring Gain-of-Function Mutant p53.

机构信息

Cancer Biology and Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, 4, Raja S.C. Mullick Road, Jadavpur, Kolkata 700032, India.

Human Genetics Unit, Indian Statistical Institute, 203 B. T. Road, Kolkata 700108, India.

出版信息

Genes (Basel). 2019 Oct 28;10(11):852. doi: 10.3390/genes10110852.

Abstract

Mutations in the gene are one of the most frequent events in cancers. Certain missense mutant p53 proteins gain oncogenic functions (gain-of-functions) and drive tumorigenesis. Apart from the coding genes, a few non-coding microRNAs (miRNAs) are implicated in mediating mutant p53-driven cancer phenotypes. Here, we identified miRNAs in mutant p53 bearing non-small cell lung carcinoma (NSCLC) cells while using small RNA deep sequencing. Differentially regulated miRNAs were validated in the TCGA lung adenocarcinoma patients with p53 mutations and, subsequently, we identified specific miRNA signatures that are associated with lymph node metastasis and poor survival of the patients. Pathway analyses with integrated miRNA-mRNA expressions further revealed potential regulatory molecular networks in mutant p53 cancer cells. A possible contribution of putative mutant p53-regulated miRNAs in epithelial-to-mesenchymal transition (EMT) is also predicted. Most importantly, we identified a novel miRNA from the unmapped sequencing reads through a systematic computational approach. The newly identified miRNA promotes proliferation, colony-forming ability, and migration of NSCLC cells. Overall, the present study provides an altered miRNA expression profile that might be useful in biomarker discovery for non-small cell lung cancers with mutations and discovers a hitherto unknown miRNA with oncogenic potential.

摘要

基因中的突变是癌症中最常见的事件之一。某些错义突变 p53 蛋白获得致癌功能(获得功能)并驱动肿瘤发生。除了编码基因外,一些非编码 microRNAs(miRNAs)也参与调节突变 p53 驱动的癌症表型。在这里,我们使用小 RNA 深度测序鉴定了携带突变 p53 的非小细胞肺癌(NSCLC)细胞中的 miRNAs。在 TCGA 肺腺癌患者中验证了差异调节的 miRNAs,这些患者存在 p53 突变,随后,我们确定了与淋巴结转移和患者生存不良相关的特定 miRNA 特征。整合 miRNA-mRNA 表达的通路分析进一步揭示了突变 p53 癌细胞中潜在的调节分子网络。还预测了假定的突变 p53 调节的 miRNAs 在上皮间质转化(EMT)中的可能贡献。最重要的是,我们通过系统的计算方法从未映射的测序reads 中鉴定出一种新的 miRNA。新鉴定的 miRNA 促进 NSCLC 细胞的增殖、集落形成能力和迁移。总的来说,本研究提供了一个改变的 miRNA 表达谱,可能对携带突变的非小细胞肺癌的生物标志物发现有用,并发现了一种具有致癌潜力的未知 miRNA。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb2e/6895929/b1f2dfa75eab/genes-10-00852-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验